Androgens activate mitogen-activated protein kinase via epidermal growth factor receptor/insulin-like growth factor 1

Mahsa Hamzeh1, Bernard Robaire

  • 1Department of Pharmacology and Therapeutics, McGill University, McIntyre Medical Sciences Building, 3655 Promenade Sir-William-Osler, Montréal, Québec, Canada.

Insights

5α-dihydrotestosterone (DHT) triggers rapid, non-genomic signaling in epididymal cells via androgen receptor (AR) activation. This pathway involves ERK activation, suggesting a novel mechanism for androgen action.

Area of Science:

  • Reproductive Biology
  • Molecular Endocrinology
  • Cell Signaling

Background:

  • Androgens are key regulators of epididymal function.
  • Classical androgen action involves androgen receptor (AR) binding to DNA.
  • Rapid, non-genomic signaling pathways are increasingly recognized.

Purpose of the Study:

  • To investigate rapid, AR-mediated signaling pathways activated by 5α-dihydrotestosterone (DHT) in epididymal cells.
  • To elucidate the role of ERK1/2 and AKT pathways in early DHT response.
  • To identify downstream signaling molecules involved in DHT-induced epididymal cell activation.

Main Methods:

  • Utilized the mouse proximal caput epididymis-1 cell line.
  • Supplemented cells with DHT and measured protein activation (AKT, ERK1/2) at early time points.
  • Investigated the role of hydroxyflutamide (HF), steroid receptor co-activator (SRC) kinase, EGFR, and IGF1R in the signaling cascade.

Main Results:

  • DHT rapidly activated the ERK1/2 pathway within 1 minute, independent of AKT activation.
  • Early ERK activation was AR-mediated and blocked by HF.
  • DHT-induced SRC activation was essential for ERK response, with EGFR and IGF1R downstream, enhancing ERK and CREB phosphorylation.

Conclusions:

  • DHT initiates a rapid, non-genomic signaling cascade in epididymal cells involving AR, SRC, EGFR/IGF1R, MEK, ERK1/2, and CREB.
  • This rapid androgen action may modulate nuclear gene transcription.
  • Identified a novel signaling pathway for androgen action in the epididymis.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...